Geode Capital Management, LLC Rapt Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 683,179 shares of RAPT stock, worth $567,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

683,179

Previous 684,713 0.22%

Holding current value

$567,038

Previous $2.09 Million 34.24%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.76 - $3.75 $2,699 - $5,752	-1,534 Reduced 0.22%	683,179 $1.37 Million
Q2 2024 Aug 09, 2024	BUY	$2.89 - $9.38 $15,886 - $51,561	5,497 Added 0.81%	684,713 $2.09 Million
Q1 2024 May 13, 2024	BUY	$6.87 - $26.45 $68,129 - $262,304	9,917 Added 1.48%	679,216 $6.1 Million
Q4 2023 Feb 13, 2024	BUY	$11.28 - $25.46 $455,858 - $1.03 Million	40,413 Added 6.43%	669,299 $16.6 Million
Q3 2023 Nov 13, 2023	BUY	$16.34 - $24.66 $1.39 Million - $2.09 Million	84,936 Added 15.61%	628,886 $10.5 Million
Q2 2023 Aug 11, 2023	BUY	$16.06 - $21.61 $247,243 - $332,685	15,395 Added 2.91%	543,950 $10.2 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $1.27 Million - $2.27 Million	73,649 Added 16.19%	528,555 $9.7 Million
Q4 2022 Feb 13, 2023	BUY	$16.28 - $24.6 $484,541 - $732,169	29,763 Added 7.0%	454,906 $9.01 Million
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $336,049 - $569,937	18,711 Added 4.6%	425,143 $10.2 Million
Q2 2022 Aug 12, 2022	BUY	$10.26 - $23.59 $367,728 - $845,489	35,841 Added 9.67%	406,432 $7.42 Million
Q1 2022 May 13, 2022	BUY	$17.02 - $40.22 $452,340 - $1.07 Million	26,577 Added 7.73%	370,591 $8.15 Million
Q4 2021 Feb 11, 2022	SELL	$29.5 - $39.5 $84,163 - $112,693	-2,853 Reduced 0.82%	344,014 $12.6 Million
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $3.56 Million - $4.71 Million	119,279 Added 52.41%	346,867 $10.8 Million
Q2 2021 Aug 13, 2021	BUY	$17.99 - $40.02 $1.04 Million - $2.32 Million	58,075 Added 34.26%	227,588 $7.24 Million
Q1 2021 May 12, 2021	BUY	$16.0 - $24.46 $408,608 - $624,659	25,538 Added 17.74%	169,513 $3.76 Million
Q4 2020 Feb 12, 2021	BUY	$15.89 - $40.87 $97,421 - $250,573	6,131 Added 4.45%	143,975 $2.84 Million
Q3 2020 Nov 13, 2020	BUY	$21.6 - $37.5 $139,276 - $241,800	6,448 Added 4.91%	137,844 $4.44 Million
Q2 2020 Aug 13, 2020	BUY	$14.16 - $32.85 $861,551 - $2 Million	60,844 Added 86.24%	131,396 $3.81 Million
Q1 2020 May 14, 2020	BUY	$11.86 - $48.86 $485,856 - $2 Million	40,966 Added 138.46%	70,552 $1.5 Million
Q4 2019 Feb 13, 2020	BUY	$12.3 - $30.78 $363,907 - $910,657	29,586 New	29,586 $816,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $24.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Rapt Therapeutics, Inc. Transaction History